What is SION's stock issuance proceeds?

SION (SION) reported stock issuance proceeds of $2.21M in Q1 2026.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Septerna, Inc.SEPN

$333K+405%

BioCryst PharmaceuticalsBCRX

$19.48M+715%

Denali Therapeutics Inc.DNLI

$12.37M—

Neurocrine BiosciencesNBIX

$23.6M-26.5%

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Market cap$1.86B—

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is SION's stock issuance proceeds?: SION (SION) reported stock issuance proceeds of $2.21M in Q1 2026.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.